title: [New perspectives in the drug therapy of hormone-resistant prostate cancer].
authors.forename: N A
authors.initials: NA
authors.lastname: Vorob'ev
authors.forename: A K
authors.initials: AK
authors.lastname: Nosov
authors.forename: A V
authors.initials: AV
authors.lastname: Vorob'ev
authors.forename: V M
authors.initials: VM
authors.lastname: Moiseenko
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D019496:Cancer Vaccines / Q000627:therapeutic use; D034261:Epothilones / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D019254:Genes, bcl-2 / Q000187:drug effects; D006360:Heat-Shock Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D013002:Somatomedins / Q000037:antagonists & inhibitors; D016896:Treatment Outcome; D050257:Tubulin Modulators / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D034261:Epothilones; D004967:Estrogens; D006360:Heat-Shock Proteins; D013002:Somatomedins; D050257:Tubulin Modulators